Global IBS-C Drug Market Overview
The global IBS-C Drug market is expected to reach USD XX Million by the end of year 2027 from USD XX Million from the year 2021. In the span of last two years, IBS-C Drug market has shown promising growth from both sides (Demand and Supply) and demand from end users is expected to rise continuously. It has also been observed that the IBS-C Drug market has registered XX% of growth rate during 2016-2021 and is estimated to register XX% of CAGR during the period 2021 to 2027.
COVID 19 Impact on IBS-C Drug Market
The COVID19 outbreak had a major impact on several industries on different levels; Some of these were border restrictions, transportation, and logistics restrictions, and worldwide bans. It also created economic uncertainty as the outbreak created a situation where both manufacturing and service industries were kept shut for very long period. Lack of availability of solution and the growing number of people infected with COVID and the uncertainty about the end of the crisis are much greater than with previous outbreaks. The pandemic has resulted in the closure of regions, border restrictions and the breakdown of transport networks.
Segment Analysis of IBS-C Drug Market
This study on IBS-C Drug market estimates and provides revenue growth at global, regional and country levels also, offers an overview of the latest developments in each of the sub-sectors from 2016 to 2027. For this analysis, READ Market Research has bifurcated the market of IBS-C Drug into Type Segment, Application Segment and Regional Segment.
The companies mentioned in the report are:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma
Astellas Pharmaceuticals
Ardelyx
Synthetic Biologics
Teva Pharmaceutical Industries
Bama-Geve
Ferring BV
Ironwood Pharmaceuticals
Salix Pharmaceuticals
Norgine
Prometheus Laboratories
Actavis Nordic
Albireo Pharma
Yuhan Corp
Astrazeneca
The Menarini Group
Ono Pharmaceutical
Note: We can also add companies which are not part of the above list
One of the very important chapter of IBS-C Drug market report is competitive analysis. In this chapter, we have presented a detailed overview of the competition and have provided the market revenue of each company along with the market share.
Global IBS-C Drug Market Analysis By Type
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Other
In the year 2021, Linaclotide segment had XX% of market share and in terms of value, the Linaclotide market was valued at USD XX Million. It is expected that Linaclotide will have XX% of market share by the end of year 2027 and the incremental growth from 2021 till 2027 is expected to be USD XX Million.
Global IBS-C Drug Market Analysis By Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies segment is expected to account for XX% of market share by the end of year 2027 from XX% in 2021. The Hospital Pharmacies segment is expected to grow at USD XX million by the end of year 2027.
Regional Analysis
Geographically, the global IBS-C Drug market has been categorized as North America, Europe, the Asia-Pacific, the Middle East & Africa, and South America. North America accounted IBS-C Drug market accounted for XX% of the market share in the year 2021 and register strong growth during the forecast period. However, the APAC area is experiencing significant growth due to various factors.
Report Scope:
Market Size: XX Million (Ask for Sample in order to view the details)
CAGR: XX% Ask for Sample in order to view the details)
Base Year: 2021
Forecast Period: 2022-2027
Forecast Units: Value (USD Million)
Geographies Covered: North America, Europe, Asia-Pacific, Middle East & Africa, South America
Frequently Asked Questions - FAQ:
What will be the dynamics for the adoption of IBS-C Drug market based on Healthcare Industry
Which product will contribute more to the overall market share by 2027
Which region is expected to adopt IBS-C Drug offerings at a fast rate
What are the key market dynamics influencing IBS-C Drug market growth How will they turn into strengths or weaknesses of companies operating in the market space
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global IBS-C Drug Market Size Growth Rate by Type (2022-2027)
1.3.2 Linaclotide
1.3.3 Lubiprostone
1.3.4 Osmotic Laxatives
1.3.5 Stimulant Laxatives
1.3.6 Other
1.4 Market Segment by Application
1.4.1 Global IBS-C Drug Market Share by Application (2022-2027)
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IBS-C Drug Market Size
2.1.1 Global IBS-C Drug Revenue 2016-2027
2.1.2 Global IBS-C Drug Sales 2016-2027
2.2 IBS-C Drug Growth Rate by Regions
2.2.1 Global IBS-C Drug Sales by Regions 2016-2021
2.2.2 Global IBS-C Drug Revenue by Regions 2016-2021
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 IBS-C Drug Sales by Manufacturers
3.1.1 IBS-C Drug Sales by Manufacturers 2016-2021
3.1.2 IBS-C Drug Sales Market Share by Manufacturers 2016-2021
3.2 Revenue by Manufacturers
3.2.1 IBS-C Drug Revenue by Manufacturers (2016-2021)
3.2.2 IBS-C Drug Revenue Share by Manufacturers (2016-2021)
3.2.3 Global IBS-C Drug Market Concentration Ratio (CR5 and HHI)
3.3 IBS-C Drug Price by Manufacturers
3.4 Key Manufacturers IBS-C Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into IBS-C Drug Market
3.6 Key Manufacturers IBS-C Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Linaclotide Sales and Revenue (2016-2021)
4.1.2 Lubiprostone Sales and Revenue (2016-2021)
4.1.3 Osmotic Laxatives Sales and Revenue (2016-2021)
4.1.4 Stimulant Laxatives Sales and Revenue (2016-2021)
4.1.5 Other Sales and Revenue (2016-2021)
4.2 Global IBS-C Drug Sales Market Share by Type
4.3 Global IBS-C Drug Revenue Market Share by Type
4.4 IBS-C Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global IBS-C Drug Sales by Application
6 United States
6.1 United States IBS-C Drug Breakdown Data by Company
6.2 United States IBS-C Drug Breakdown Data by Type
6.3 United States IBS-C Drug Breakdown Data by Application
7 European Union
7.1 European Union IBS-C Drug Breakdown Data by Company
7.2 European Union IBS-C Drug Breakdown Data by Type
7.3 European Union IBS-C Drug Breakdown Data by Application
8 China
8.1 China IBS-C Drug Breakdown Data by Company
8.2 China IBS-C Drug Breakdown Data by Type
8.3 China IBS-C Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World IBS-C Drug Breakdown Data by Company
9.2 Rest of World IBS-C Drug Breakdown Data by Type
9.3 Rest of World IBS-C Drug Breakdown Data by Application
9.4 Rest of World IBS-C Drug Breakdown Data by Countries
9.4.1 Rest of World IBS-C Drug Sales by Countries
9.4.2 Rest of World IBS-C Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Catalent Pharmaceuticals Solutions
10.1.1 Catalent Pharmaceuticals Solutions Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of IBS-C Drug
10.1.4 IBS-C Drug Product Introduction
10.1.5 Catalent Pharmaceuticals Solutions Recent Development
10.2 Nestle
10.2.1 Nestle Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of IBS-C Drug
10.2.4 IBS-C Drug Product Introduction
10.2.5 Nestle Recent Development
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of IBS-C Drug
10.3.4 IBS-C Drug Product Introduction
10.3.5 Abbott Laboratories Recent Development
10.4 Synergy Pharmaceuticals
10.4.1 Synergy Pharmaceuticals Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of IBS-C Drug
10.4.4 IBS-C Drug Product Introduction
10.4.5 Synergy Pharmaceuticals Recent Development
10.5 Sucampo Pharmaceuticals
10.5.1 Sucampo Pharmaceuticals Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of IBS-C Drug
10.5.4 IBS-C Drug Product Introduction
10.5.5 Sucampo Pharmaceuticals Recent Development
10.6 Novartis Pharma
10.6.1 Novartis Pharma Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of IBS-C Drug
10.6.4 IBS-C Drug Product Introduction
10.6.5 Novartis Pharma Recent Development
10.7 Astellas Pharmaceuticals
10.7.1 Astellas Pharmaceuticals Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of IBS-C Drug
10.7.4 IBS-C Drug Product Introduction
10.7.5 Astellas Pharmaceuticals Recent Development
10.8 Ardelyx
10.8.1 Ardelyx Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of IBS-C Drug
10.8.4 IBS-C Drug Product Introduction
10.8.5 Ardelyx Recent Development
10.9 Synthetic Biologics
10.9.1 Synthetic Biologics Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of IBS-C Drug
10.9.4 IBS-C Drug Product Introduction
10.9.5 Synthetic Biologics Recent Development
10.10 Teva Pharmaceutical Industries
10.10.1 Teva Pharmaceutical Industries Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of IBS-C Drug
10.10.4 IBS-C Drug Product Introduction
10.10.5 Teva Pharmaceutical Industries Recent Development
10.11 Bama-Geve
10.12 Ferring BV
10.13 Ironwood Pharmaceuticals
10.14 Salix Pharmaceuticals
10.15 Norgine
10.16 Prometheus Laboratories
10.17 Actavis Nordic
10.18 Albireo Pharma
10.19 Yuhan Corp
10.20 Astrazeneca
10.21 The Menarini Group
10.22 Ono Pharmaceutical
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 IBS-C Drug Sales Channels
11.2.2 IBS-C Drug Distributors
11.3 IBS-C Drug Customers
12 Market Forecast
12.1 Global IBS-C Drug Sales and Revenue Forecast 2022-2027
12.2 Global IBS-C Drug Sales Forecast by Type
12.3 Global IBS-C Drug Sales Forecast by Application
12.4 IBS-C Drug Forecast by Regions
12.4.1 Global IBS-C Drug Sales Forecast by Regions 2022-2027
12.4.2 Global IBS-C Drug Revenue Forecast by Regions 2022-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Disclaimer
List of Tables and Figures
Figure IBS-C Drug Product Picture
Table IBS-C Drug Key Market Segments
Table Major Manufacturers IBS-C Drug Covered in This Report
Table Global IBS-C Drug Market Size Growth Rate by Type 2022-2027 (K Units) & (Million US$)
Figure Global IBS-C Drug Sales Market Shar by Type 2016-2027
Figure Linaclotide Figures
Table Major Manufacturers of Linaclotide
Figure Lubiprostone Figures
Table Major Manufacturers of Lubiprostone
Figure Osmotic Laxatives Figures
Table Major Manufacturers of Osmotic Laxatives
Figure Stimulant Laxatives Figures
Table Major Manufacturers of Stimulant Laxatives
Figure Other Figures
Table Major Manufacturers of Other
Table Global IBS-C Drug Market Share by Application 2022-2027 (K Units)
Figure Hospital Pharmacies Use Case
Figure Retail Pharmacies Use Case
Figure Online Pharmacies Use Case
Figure IBS-C Drug Report Years Considered
Figure Global IBS-C Drug Market Size 2016-2027 (Million US$)
Figure Global IBS-C Drug Sales 2016-2021 (K Units)
Table Global IBS-C Drug Market Size by Regions 2016-2021 (K Units) & (Million US$)
Table Global IBS-C Drug Sales by Regions 2016-2021 (K Units)
Table Global IBS-C Drug Sales Market Share by Regions 2016-2021
Figure Global IBS-C Drug Sales Market Share by Regions 2016-2021
Figure Global IBS-C Drug Sales Market Share by Regions in 2021
Table Global IBS-C Drug Revenue by Regions 2016-2021 (Million US$)
Table Global IBS-C Drug Revenue Market Share by Regions 2016-2021
Figure Global IBS-C Drug Revenue Market Share by Regions 2016-2021
Figure Global IBS-C Drug Revenue Market Share by Regions in 2021
Table Market Top Trends
Table Global IBS-C Drug Sales by Manufacturers (2016-2021) (K Units)
Table Global IBS-C Drug Sales Share by Manufacturers (2016-2021)
Figure Global IBS-C Drug Sales Share by Manufacturers in 2021
Table IBS-C Drug Revenue by Manufacturers (2016-2021) (Million USD)
Table IBS-C Drug Revenue Share by Manufacturers (2016-2021)
Figure IBS-C Drug Value Share by Manufacturers in 2021
Table Global IBS-C Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers IBS-C Drug Price (2016-2021) (USD/Unit)
Table Key Manufacturers IBS-C Drug Plants/Factories Distribution
Table Key Manufacturers IBS-C Drug Area Served
Table Date of Key Manufacturers Enter into IBS-C Drug Market
Table Key Manufacturers IBS-C Drug Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Linaclotide Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global Lubiprostone Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global Osmotic Laxatives Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global Stimulant Laxatives Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global Other Sales and Revenue (2016-2021) (K Units) & (Million US$)
Table Global IBS-C Drug Sales by Type (2016-2021) (K Units)
Table Global IBS-C Drug Sales Share by Type (2016-2021)
Figure Global IBS-C Drug Sales Market Share by Type (2016-2021)
Figure Global IBS-C Drug Sales Market Share by Type in 2021
Table Global IBS-C Drug Revenue by Type (2016-2021) (Million US$)
Table Global IBS-C Drug Revenue Share by Type (2016-2021)
Figure Global IBS-C Drug Revenue Market Share by Type (2016-2021)
Figure Global IBS-C Drug Revenue Market Share by Type in 2021
Table IBS-C Drug Price by Type 2016-2021 (USD/Unit)
Table Global IBS-C Drug Sales by Application (2016-2021) (K Units)
Table Global IBS-C Drug Sales Share by Application (2016-2021)
Figure Global Sales IBS-C Drug Market Share by Application (2016-2021)
Figure Global Sales IBS-C Drug Market Share by Application (2016-2021)
Figure United States IBS-C Drug Sales Growth Rate 2016-2021 (K Units)
Figure United States IBS-C Drug Revenue Growth Rate 2016-2021 (Million US$)
Table United States IBS-C Drug Sales by Company (2016-2021) (K Units)
Table United States IBS-C Drug Sales Market Share by Company (2016-2021)
Figure United States IBS-C Drug Sales Market Share by Company in 2021
Table United States IBS-C Drug Sales by Type (2016-2021) (K Units)
Table United States IBS-C Drug Sales Market Share by Type (2016-2021)
Figure United States IBS-C Drug Market Share by Type in 2021
Table United States IBS-C Drug Sales by Application (2016-2021) (K Units)
Table United States IBS-C Drug Sales Market Share by Application (2016-2021)
Figure United States IBS-C Drug Market Share by Application in 2021
Figure European Union IBS-C Drug Sales Growth Rate 2016-2021 (K Units)
Figure European Union IBS-C Drug Revenue Growth Rate 2016-2021 (Million US$)
Table European Union IBS-C Drug Sales by Company (2016-2021) (K Units)
Table European Union IBS-C Drug Sales Market Share by Company (2016-2021)
Figure European Union IBS-C Drug Sales Market Share by Company in 2021
Table European Union IBS-C Drug Sales by Type (2016-2021) (K Units)
Table European Union IBS-C Drug Sales Market Share by Type (2016-2021)
Figure European Union IBS-C Drug Market Share by Type
Table European Union IBS-C Drug Sales by Application (2016-2021) (K Units)
Table European Union IBS-C Drug Sales Market Share by Application (2016-2021)
Figure European Union IBS-C Drug Market Share by Application
Figure China IBS-C Drug Sales Growth Rate 2016-2021 (K Units)
Figure China IBS-C Drug Revenue Growth Rate 2016-2021 (Million US$)
Table China IBS-C Drug Sales by Company (2016-2021) (K Units)
Table China IBS-C Drug Sales Market Share by Company (2016-2021)
Figure China IBS-C Drug Sales Market Share by Company in 2021
Table China IBS-C Drug Sales by Type (2016-2021) (K Units)
Table China IBS-C Drug Sales Market Share by Type (2016-2021)
Figure China IBS-C Drug Market Share by Type in 2021
Table China IBS-C Drug Sales by Application (2016-2021) (K Units)
Table China IBS-C Drug Sales Market Share by Application (2016-2021)
Figure China IBS-C Drug Market Share by Application in 2021
Figure Rest of World IBS-C Drug Sales Growth Rate 2016-2021 (K Units)
Figure Rest of World IBS-C Drug Revenue Growth Rate 2016-2021 (Million US$)
Table Rest of World IBS-C Drug Sales by Company (2016-2021) (K Units)
Table Rest of World IBS-C Drug Sales Market Share by Company (2016-2021)
Figure Rest of World IBS-C Drug Sales Market Share by Company in 2021
Table Rest of World IBS-C Drug Sales by Type (2016-2021) (K Units)
Table Rest of World IBS-C Drug Sales Market Share by Type (2016-2021)
Figure Rest of World IBS-C Drug Market Share by Type in 2021
Table Rest of World IBS-C Drug Sales by Application (2016-2021) (K Units)
Table Rest of World IBS-C Drug Sales Market Share by Application (2016-2021)
Figure Rest of World IBS-C Drug Market Share by Application in 2021
Table Rest of World IBS-C Drug Sales by Countries (2016-2021) (K Units)
Table Rest of World IBS-C Drug Sales Market Share by Countries (2016-2021)
Figure Rest of World IBS-C Drug Sales Market Share by Countries in 2021
Table Rest of World IBS-C Drug Revenue by Countries (2016-2021) (Million US$)
Table Rest of World IBS-C Drug Revenue Market Share by Countries (2016-2021)
Figure Rest of World IBS-C Drug Revenue Market Share by Countries in 2021
Figure Japan IBS-C Drug Sales Growth Rate (2016-2021) (K Units)
Figure Japan IBS-C Drug Revenue Growth Rate (2016-2021) (K Units)
Figure Korea IBS-C Drug Sales Growth Rate (2016-2021) (K Units)
Figure Korea IBS-C Drug Revenue Growth Rate (2016-2021) (K Units)
Figure India IBS-C Drug Sales Growth Rate (2016-2021) (K Units)
Figure India IBS-C Drug Revenue Growth Rate (2016-2021) (K Units)
Figure Southeast Asia IBS-C Drug Sales Growth Rate (2016-2021) (K Units)
Figure Southeast Asia IBS-C Drug Revenue Growth Rate (2016-2021) (K Units)
Table Catalent Pharmaceuticals Solutions Company Details
Table Catalent Pharmaceuticals Solutions Description and Business Overview
Table Catalent Pharmaceuticals Solutions IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Catalent Pharmaceuticals Solutions IBS-C Drug Sales Growth Rate (2016-2021)
Table Catalent Pharmaceuticals Solutions IBS-C Drug Sales Market Share in Global Market
Table Catalent Pharmaceuticals Solutions Recent Development
Table Nestle Company Details
Table Nestle Description and Business Overview
Table Nestle IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Nestle IBS-C Drug Sales Growth Rate (2016-2021)
Table Nestle IBS-C Drug Sales Market Share in Global Market
Table Nestle Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Description and Business Overview
Table Abbott Laboratories IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Abbott Laboratories IBS-C Drug Sales Growth Rate (2016-2021)
Table Abbott Laboratories IBS-C Drug Sales Market Share in Global Market
Table Abbott Laboratories Recent Development
Table Synergy Pharmaceuticals Company Details
Table Synergy Pharmaceuticals Description and Business Overview
Table Synergy Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Synergy Pharmaceuticals IBS-C Drug Sales Growth Rate (2016-2021)
Table Synergy Pharmaceuticals IBS-C Drug Sales Market Share in Global Market
Table Synergy Pharmaceuticals Recent Development
Table Sucampo Pharmaceuticals Company Details
Table Sucampo Pharmaceuticals Description and Business Overview
Table Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Sucampo Pharmaceuticals IBS-C Drug Sales Growth Rate (2016-2021)
Table Sucampo Pharmaceuticals IBS-C Drug Sales Market Share in Global Market
Table Sucampo Pharmaceuticals Recent Development
Table Novartis Pharma Company Details
Table Novartis Pharma Description and Business Overview
Table Novartis Pharma IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Novartis Pharma IBS-C Drug Sales Growth Rate (2016-2021)
Table Novartis Pharma IBS-C Drug Sales Market Share in Global Market
Table Novartis Pharma Recent Development
Table Astellas Pharmaceuticals Company Details
Table Astellas Pharmaceuticals Description and Business Overview
Table Astellas Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Astellas Pharmaceuticals IBS-C Drug Sales Growth Rate (2016-2021)
Table Astellas Pharmaceuticals IBS-C Drug Sales Market Share in Global Market
Table Astellas Pharmaceuticals Recent Development
Table Ardelyx Company Details
Table Ardelyx Description and Business Overview
Table Ardelyx IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Ardelyx IBS-C Drug Sales Growth Rate (2016-2021)
Table Ardelyx IBS-C Drug Sales Market Share in Global Market
Table Ardelyx Recent Development
Table Synthetic Biologics Company Details
Table Synthetic Biologics Description and Business Overview
Table Synthetic Biologics IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Synthetic Biologics IBS-C Drug Sales Growth Rate (2016-2021)
Table Synthetic Biologics IBS-C Drug Sales Market Share in Global Market
Table Synthetic Biologics Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Description and Business Overview
Table Teva Pharmaceutical Industries IBS-C Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table Teva Pharmaceutical Industries IBS-C Drug Sales Growth Rate (2016-2021)
Table Teva Pharmaceutical Industries IBS-C Drug Sales Market Share in Global Market
Table Teva Pharmaceutical Industries Recent Development
Table Bama-Geve Company Details
Table Ferring BV Company Details
Table Ironwood Pharmaceuticals Company Details
Table Salix Pharmaceuticals Company Details
Table Norgine Company Details
Table Prometheus Laboratories Company Details
Table Actavis Nordic Company Details
Table Albireo Pharma Company Details
Table Yuhan Corp Company Details
Table Astrazeneca Company Details
Table The Menarini Group Company Details
Table Ono Pharmaceutical Company Details
Figure IBS-C Drug Value Chain
Table IBS-C Drug Distributors List
Table IBS-C Drug Customers List
Table Global IBS-C Drug Sales Forecast 2022-2027 (K Units) & (Million US$)
Figure Global IBS-C Drug Sales Forecast 2022-2027 (K Units)
Figure Global IBS-C Drug Revenue Forecast 2022-2027 (Million US$)
Table Global IBS-C Drug Sales Forecast by Type 2022-2027 (K Units)
Figure Global IBS-C Drug Sales Forecast by Type 2022-2027 (K Units)
Figure Global IBS-C Drug Sales Market Share Forecast by Type 2022-2027
Table Global IBS-C Drug Sales Forecast by Application 2022-2027 (K Units)
Figure Global IBS-C Drug Sales Forecast by Application 2022-2027 (K Units)
Figure Global IBS-C Drug Sales Market Share Forecast by Application 2022-2027
Table Global IBS-C Drug Sales Forecast by Regions 2022-2027 (K Units)
Figure Global IBS-C Drug Sales Forecast by Regions 2022-2027 (K Units)
Figure Global IBS-C Drug Sales Market Share Forecast by Regions 2022-2027
Table Global IBS-C Drug Revenue Forecast by Regions 2022-2027 (K Units)
Figure Global IBS-C Drug Revenue Forecast by Regions 2022-2027 (K Units)
Figure Global IBS-C Drug Revenue Market Share Forecast by Regions 2022-2027
Figure United States IBS-C Drug Sales Forecast 2022-2027 (K Units)
Figure United States IBS-C Drug Revenue Forecast 2022-2027 (Million US$)
Figure European Union IBS-C Drug Sales Forecast 2022-2027 (K Units)
Figure European Union IBS-C Drug Revenue Forecast 2022-2027 (Million US$)
Figure China IBS-C Drug Sales Forecast 2022-2027 (K Units)
Figure China IBS-C Drug Revenue Forecast 2022-2027 (Million US$)
Figure Japan IBS-C Drug Sales Forecast 2022-2027 (K Units)
Figure Japan IBS-C Drug Revenue Forecast 2022-2027 (Million US$)
Figure Korea IBS-C Drug Sales Forecast 2022-2027 (K Units)
Figure Korea IBS-C Drug Revenue Forecast 2022-2027 (Million US$)
Figure India IBS-C Drug Sales Forecast 2022-2027 (K Units)
Figure India IBS-C Drug Revenue Forecast 2022-2027 (Million US$)
Figure Southeast Asia IBS-C Drug Sales Forecast 2022-2027 (K Units)
Figure Southeast Asia IBS-C Drug Revenue Forecast 2022-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources